Atlas Trials

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility

Clinical trial NCT01902290 · TERMINATED

Trial details

NCT number
NCT01902290
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2013-05-22
Primary completion
2015-05-15
Enrollment
421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.